Inhibition of human immunodeficiency virus type 1 replication in cytokinestimulated monocytesjmacrophages by combination therapy

Journal of Infectious Diseases

Volumn 170, Issue 6, 1994, Pages 1361-1366

  Rusconi, Stefano ^a,b   Merrill, Debra P ^a   Hirsch, Martin S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 [(4,7 DICHLORO 2 BENZOXAZOLYLMETHYL)AMINO] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; [7 CHLORO 5 (1H PYRROL 2 YL) 3H BENZO[E][1,4]DIAZEPIN 2 YL]METHYLAMINE; ALPHA INTERFERON; DIDANOSINE; FOSCARNET; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MIGLUSTAT; NEVIRAPINE; PYRIDONE DERIVATIVE; SAQUINAVIR; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; PRIORITY JOURNAL; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELLS, CULTURED; COMPARATIVE STUDY; DRUG COMBINATIONS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV CORE PROTEIN P24; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMAN; INTERFERON-ALPHA; MACROPHAGES; MONOCYTES; PYRIDONES; REVERSE TRANSCRIPTASE INHIBITORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRUS REPLICATION;

EID: 0028143721     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.6.1361     Document Type: Article

References (24)

1. Gartner S. Markovits P, Markovitz DM, Kaplan Mil. Gallo RC, Popo-vic M. The role of mononuclear phagocytes in HTLV-UI/LAV infection. Science 1986;233:215-9.
2. Ho DD, Rota TR, Hirsch MS. Infection of monocyte/macrophages by human T lymphotropie virus type 111. J Clin Invest 1986; 77; 1712-5.
3. Vazeux R. AIDS encephalopathy and tropism of HIV for brain monocytes/macrophages and microglial cells. Pathobiology 1991; 59:214-8.
4. Genis P, Jett M, Bernton EW, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HlV)-in-fected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease. J Exp Med 1992;176:1703-18.
5. Tardieu M, Hery C, Peudenicr S, Boespflug O, Montagner L. Human immunodeficiency virus type 1-infected monocytic cells can destroy human neural cells after cell-to-cell adhesion. Ann Neurol 1992;32:11-7.
6. Perno CF. Yarchoan R. Cooney DA, et al. Inhibition of human immunodeficiency virus (HIV-l/HTLV-IIIBa.L) replication in fresh and cultured human peripheral monocytes/macrophages by azidothymi-dine and related 2', 3'-dideoxynucleosides. J Exp Med 1988; 168:1111-25.
7. Perno CF, Yarchoan R, Cooney DA, et al. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effects mediated by 3'-azido-2'-3'-dideox-ythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989; 169:933-51.
8. Harbison MA, Gillis JM, Pinkston P, Byrn RA, Rose RM. Hammer SM. Effects of recombinant soluble CD4 (rCD4) on HIV-1 infection in monocyte/macrophages. J Infect Dis 1990; 161:1-6.
9. Perno CF, Cooney DA, Currens MJ, et al. Ability of anti-HIV agents to inhibit HIV replication in monocyte/macrophages orU937 monocyt-oid cells under conditions of enhancement by GM-CSF or anti-HIV antibody. AIDS Res Hum Retroviruses 1990;6:1051-5.
10. Bergamini A, Perno CF, Balzarini J, et al. Selective inhibition of HIV replication by adriamycin in macrophages but not in lymphocytes. AIDS Res Hum Retroviruses 1992;8:1239-47.
11. Gochi K, Sinet M, Dazza MC, Dameron G, Brun-Vezinet F. Anti-human immunodeficiency virus effects of zidovudine in combination with double-stranded RNA poly Lpoly C in T cells and monocytes-macrophages. AIDS Res Hum Retroviruses 1992;8:1215-9.
12. Kageyama S, Weinstein JN, Shirasaka T, et al. In vitro inhibition of human immunodeficiency virus (HIV) type I replication by C2 symmetry based HIV protease inhibitors as single agents or in combinations. Antimicrob Agents Chemother 1992;36:926-33.
13. Mazzulli T, Hirsch MS. Combination therapy for HIV-1 infection. In: Mills J, Corey L, eds. New directions in antiviral therapy. New York: Elseiver, 1992:385-416.
14. Caliendo AM, Hirsch MS. Combination therapy for HIV-1 infection. Clin Infect Dis 1994;18:516-24.
15. Ratner L, Fisher A, Jagodzinski LL, et al. Complete nucleotide sequence of functional clones of the AIDS virus. AIDS Res Hum Retroviruses 1987;3:57-69.
16. Chou TC, Talalay P. Quantitative analysis of dose effect relationships: The combined effect of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1981;22:27-55.
17. Chou JH, Chou TC. Dose-effect analysis with microcomputers: Quantitation of ED50, LD50, synergism, antagonism, low-dose risk, recep-tor-!igand binding and enzyme kinetics: A computer software for IBM-PC and manual. Cambridge. UK: Elsevier-Biosoft, 1986.
18. Chou TC. The median-eflect principle and the combination index for quantitation of synergism and antagonism. In: Chou TC. Rideout DC, eds. Synergism and antagonism in chemotherapy. New York: Academic Press, 1991:61 -102.
19. Johnson VA, Byington RE. Modified HIV-1 p24 antigen ELISA. In: Aldovini A. Walker B, eds. Techniques in HIV research. New York: Stockton Press. 1990:95-7.
20. Hirsch MS, D'Aquila RT. Therapy for human immunodeficiency virus infection. N Engl J Med 1993;328:1686-95.
21. Mazzulli T, Rusconi S, Merrill DP, et al. Combination chemotherapy of HIV-1 infection in vitro: Alternating versus continuous drug regimens. Antimicrob Agents Chemother 1994;38:656-61.
22. Perno CF, Bergamini A, Pesce CD, et al. Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J Infect Dis 1993;168:1148-56.
23. Richman DD, Kornbluth RS, Carson DA. Failure of dideoxynucleo-sides to inhibit human immunodeficiency virus replication in cultured human macrophages. J Exp Med 1987:166:1 144-9.
24. Gao WY, Shirasaka T. Johns DG, Broder S, Mitsuya H. Differential phosphorylation ofazidothymidine. dideoxycylidine. and dideoxyin-osine in resting and activated peripheral blood mononuclear cells. J Ciin Invest 1993;91:2326-33.